Evolus Scientific Investor Presentation March 2024

Evolus presents its investment case for Jeuveau® and pipeline candidates including Evolysse. The presentation outlines the company's commercial strategy, product performance, and regulatory programs, with forward-looking guidance on market adoption and clinical development timelines.